HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
25 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
OPTN
optineurin
Chromosome 10 Β· 10p13
NCBI Gene: 10133Ensembl: ENSG00000123240.18HGNC: HGNC:17142UniProt: Q96CV9
302PubMed Papers
23Diseases
0Drugs
66Pathogenic Variants
FUNCTIONAL ROLE
Hub Gene
RESEARCH IMPACT
TrendingVariant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein bindingprotein-macromolecule adaptor activitypolyubiquitin modification-dependent protein bindingidentical protein bindingfamilial amyotrophic lateral sclerosisopen-angle glaucomaamyotrophic lateral sclerosisgenetic disorder
✦AI Summary

OPTN (optineurin) is a multifunctional autophagy receptor that plays critical roles in cellular homeostasis and neuroprotection. Its primary function involves selective autophagy, particularly mitophagy, where it recognizes and targets damaged mitochondria for degradation 1. OPTN facilitates mitochondrial transport by directly interacting with microtubules and the TRAK1/KIF5B transport complex, stabilizing them for proper anterograde axonal mitochondrial delivery 2. The protein also regulates cell fate decisions in mesenchymal stem cells by clearing FABP3 through selective autophagy, thereby maintaining bone-fat balance 3. Additionally, OPTN suppresses RIPK1-dependent inflammatory signaling and necroptosis 4. OPTN mutations are associated with amyotrophic lateral sclerosis (ALS) and normal tension glaucoma (NTG) 52. Loss of OPTN function leads to progressive neurodegeneration, including dysmyelination, axonal degeneration, and retinal ganglion cell death 42. In liver injury models, OPTN-mediated mitophagy preserves mitochondrial homeostasis and protects against drug-induced hepatotoxicity 6. The protein's neuroprotective effects depend on its C-terminus, and truncation mutations cause late-onset neurodegeneration, establishing OPTN as crucial for neuronal survival and axonal integrity.

Sources cited
1
OPTN functions as an autophagy receptor involved in cargo recognition, autophagosome formation, and lysosomal quality control
PMID: 33783320
2
OPTN directly interacts with microtubules and TRAK1/KIF5B complex for axonal mitochondrial transport and C-terminus truncation causes neurodegeneration
PMID: 39979261
3
OPTN regulates mesenchymal stem cell fate by clearing FABP3 through selective autophagy to maintain bone-fat balance
PMID: 33143524
4
OPTN suppresses RIPK1-dependent signaling and its loss leads to progressive dysmyelination and axonal degeneration through necroptotic machinery
PMID: 27493188
5
OPTN mutations cause familial normal tension glaucoma with early onset and progressive visual field loss
PMID: 37353142
6
OPTN-mediated mitophagy preserves mitochondrial homeostasis and protects against drug-induced liver injury
PMID: 39099169
Disease Associationsβ“˜23
familial amyotrophic lateral sclerosisOpen Targets
0.77Strong
open-angle glaucomaOpen Targets
0.77Strong
amyotrophic lateral sclerosisOpen Targets
0.71Strong
genetic disorderOpen Targets
0.50Moderate
osteitis deformansOpen Targets
0.47Moderate
motor neuron diseaseOpen Targets
0.45Moderate
sarcoidosisOpen Targets
0.34Weak
frontotemporal dementiaOpen Targets
0.27Weak
frontotemporal dementia with motor neuron diseaseOpen Targets
0.27Weak
neurodegenerative diseaseOpen Targets
0.19Weak
infectionOpen Targets
0.11Weak
neoplasmOpen Targets
0.10Suggestive
hepatocellular carcinomaOpen Targets
0.09Suggestive
Parkinson diseaseOpen Targets
0.09Suggestive
viral diseaseOpen Targets
0.09Suggestive
glaucomaOpen Targets
0.09Suggestive
cancerOpen Targets
0.08Suggestive
acute myeloid leukemiaOpen Targets
0.08Suggestive
type 2 diabetes mellitusOpen Targets
0.08Suggestive
Ocular MelanomaOpen Targets
0.07Suggestive
Amyotrophic lateral sclerosis 12 with or without frontotemporal dementiaUniProt
Glaucoma 1, open angle, EUniProt
Glaucoma, normal pressureUniProt
Pathogenic Variants66
NM_001008212.2(OPTN):c.235C>T (p.Gln79Ter)Pathogenic
Glaucoma 1, open angle, E;Primary open angle glaucoma;Amyotrophic lateral sclerosis type 12|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 79
NM_001008212.2(OPTN):c.493C>T (p.Gln165Ter)Pathogenic
Amyotrophic lateral sclerosis type 10|Primary open angle glaucoma;Amyotrophic lateral sclerosis type 12;Glaucoma 1, open angle, E|Amyotrophic lateral sclerosis type 12
β˜…β˜…β˜†β˜†2025β†’ Residue 165
NM_001008212.2(OPTN):c.1241_1242del (p.Glu414fs)Pathogenic
Amyotrophic lateral sclerosis type 12;Primary open angle glaucoma;Glaucoma 1, open angle, E|Amyotrophic lateral sclerosis type 12
β˜…β˜…β˜†β˜†2025β†’ Residue 414
NM_001008212.2(OPTN):c.76dup (p.His26fs)Pathogenic
not provided|Primary open angle glaucoma;Amyotrophic lateral sclerosis type 12;Glaucoma 1, open angle, E|OPTN-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 26
NM_001008212.2(OPTN):c.626+1G>ALikely pathogenic
Primary open angle glaucoma;Amyotrophic lateral sclerosis type 12;Glaucoma 1, open angle, E|Inborn genetic diseases|not provided
β˜…β˜…β˜†β˜†2025
NM_001008212.2(OPTN):c.127C>T (p.Gln43Ter)Pathogenic
not provided|Primary open angle glaucoma;Glaucoma 1, open angle, E;Amyotrophic lateral sclerosis type 12
β˜…β˜…β˜†β˜†2025β†’ Residue 43
NM_001008212.2(OPTN):c.785C>A (p.Ser262Ter)Pathogenic
Amyotrophic lateral sclerosis type 12;Primary open angle glaucoma;Glaucoma 1, open angle, E|Inborn genetic diseases
β˜…β˜…β˜†β˜†2025β†’ Residue 262
NM_001008212.2(OPTN):c.1003C>T (p.Gln335Ter)Pathogenic
Inborn genetic diseases|OPTN-related disorder|Primary open angle glaucoma;Glaucoma 1, open angle, E;Amyotrophic lateral sclerosis type 12
β˜…β˜…β˜†β˜†2025β†’ Residue 335
NM_001008212.2(OPTN):c.381_382insAG (p.Asp128fs)Pathogenic
Amyotrophic lateral sclerosis type 12;Primary open angle glaucoma;Glaucoma 1, open angle, E|not provided|Glaucoma 1, open angle, E|OPTN-related disorder|Amyotrophic lateral sclerosis type 12;Primary open angle glaucoma
β˜…β˜…β˜†β˜†2024β†’ Residue 128
NM_001008212.2(OPTN):c.1149-2A>GLikely pathogenic
not provided|Glaucoma 1, open angle, E;Primary open angle glaucoma;Amyotrophic lateral sclerosis type 12
β˜…β˜…β˜†β˜†2024
NM_001008212.2(OPTN):c.780-2A>CLikely pathogenic
Amyotrophic lateral sclerosis type 12|Primary open angle glaucoma;Amyotrophic lateral sclerosis type 12;Glaucoma 1, open angle, E
β˜…β˜…β˜†β˜†2024
NM_001008212.2(OPTN):c.918_922del (p.Thr307fs)Pathogenic
not provided|Primary open angle glaucoma;Amyotrophic lateral sclerosis type 12;Glaucoma 1, open angle, E|Amyotrophic lateral sclerosis type 12
β˜…β˜…β˜†β˜†2024β†’ Residue 307
NM_001008212.2(OPTN):c.565G>T (p.Glu189Ter)Pathogenic
not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 189
NM_001008212.2(OPTN):c.1078_1079del (p.Lys360fs)Pathogenic
Amyotrophic lateral sclerosis type 12|not provided|Primary open angle glaucoma;Glaucoma 1, open angle, E;Amyotrophic lateral sclerosis type 12
β˜…β˜…β˜†β˜†2024β†’ Residue 360
NM_001008212.2(OPTN):c.1204_1210del (p.Asn401_Asn402insTer)Pathogenic
OPTN-related disorder|Primary open angle glaucoma;Amyotrophic lateral sclerosis type 12;Glaucoma 1, open angle, E
β˜…β˜…β˜†β˜†2024β†’ Residue 401
NM_001008212.2(OPTN):c.375del (p.Thr126fs)Likely pathogenic
not provided
β˜…β˜…β˜†β˜†2023β†’ Residue 126
NM_001008212.2(OPTN):c.1195G>T (p.Glu399Ter)Pathogenic
Primary open angle glaucoma;Amyotrophic lateral sclerosis type 12;Glaucoma 1, open angle, E|not provided
β˜…β˜…β˜†β˜†2023β†’ Residue 399
NM_001008212.2(OPTN):c.1304dup (p.Ala436fs)Pathogenic
not provided|Primary open angle glaucoma;Amyotrophic lateral sclerosis type 12;Glaucoma 1, open angle, E
β˜…β˜…β˜†β˜†2022β†’ Residue 436
NM_001008212.2(OPTN):c.523del (p.Glu175fs)Pathogenic
Amyotrophic lateral sclerosis type 12;Primary open angle glaucoma;Glaucoma 1, open angle, E
β˜…β˜†β˜†β˜†2026β†’ Residue 175
NM_001008212.2(OPTN):c.148del (p.Glu50fs)Pathogenic
Amyotrophic lateral sclerosis type 12;Primary open angle glaucoma;Glaucoma 1, open angle, E
β˜…β˜†β˜†β˜†2026β†’ Residue 50
View on ClinVar β†—
Related Genes
CALCOCO2Protein interaction100%BNIP3LProtein interaction100%MAP1AProtein interaction100%SQSTM1Protein interaction100%BCL2L13Protein interaction100%UBQLN1Protein interaction100%
Tissue Expression6 tissues
Heart
100%
Brain
69%
Ovary
56%
Lung
47%
Liver
35%
Bone Marrow
18%
Gene Interaction Network
Click a node to explore
OPTNCALCOCO2BNIP3LMAP1ASQSTM1BCL2L13UBQLN1
PROTEIN STRUCTURE
Preparing viewer…
PDB3VTV Β· 1.70 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.88LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.68 [0.53–0.88]
RankingsWhere OPTN stands among ~20K protein-coding genes
  • #1,153of 20,598
    Most Researched302 Β· top 10%
  • #1,096of 5,498
    Most Pathogenic Variants66 Β· top quartile
  • #7,770of 17,882
    Most Constrained (LOEUF)0.88
Genes detectedOPTN
Sources retrieved25 papers
Response timeβ€”
πŸ“„ Sources
25β–Ό
1
ALS Genetics: Gains, Losses, and Implications for Future Therapies.
PMID: 32931756
Neuron Β· 2020
1.00
2
Emerging views of OPTN (optineurin) function in the autophagic process associated with disease.
PMID: 33783320
Autophagy Β· 2022
0.90
3
RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS.
PMID: 27493188
Science Β· 2016
0.80
4
AAA+ ATPase chaperone p97/VCP
PMID: 39472561
Nat Commun Β· 2024
0.72
5
Preserving mitochondrial homeostasis protects against drug-induced liver injury via inducing OPTN (optineurin)-dependent Mitophagy.
PMID: 39099169
Autophagy Β· 2024
0.70